logo
  1. Home
  2. Stocks
  3. Alembic Pharmaceuticals

Alembic Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | NSE: APLLTD | BSE: 533573

₹881.25 image-5.90 (-0.67 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 894.95

High (₹) 903.00

Low (₹) 863.55

Prev. Close (₹) 887.15

Volume 1,86,096

VWAP (₹) 746.25

ROCE (%) 13.80

Industry P/E 44.73

TTM P/E 28.64

P/B Ratio 3.59

Market Cap (₹) Cr.17,322.13

Dividend Yield (%)1.25

EPS (₹) 31.33

ROE12.78%

Sales Growth (%) 10.19

Profit Growth (%)65.40

Day Range

903.00903.00

L
H

52 Week Range

725.601,296.15

L
H

Historical Returns

Returns (6M)

-27.64 %

Returns (1Y)

-12.62 %

Returns (3Y)

15.95 %

Returns (5Y)

44.42 %

Returns (6M)

-27.64 %

Returns (1Y)

-12.62 %

Returns (3Y)

15.95 %

Returns (5Y)

44.42 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (80.06%) TTM EPS Growth
  • Company with Low Debt
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 80.06% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 13.66

MFI 7.17

ATR 32.35

Commodity Channel Index -141.26

ROC125 -29.18

ROC21 -18.38

Williams %R -94.91

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current766.71789.78805.61750.88727.81711.98688.91
Week Ago816.30829.20837.35808.15795.25787.10774.20
Month Ago927.55956.80982.55901.80872.55846.80817.55

EMA & SMA
info_icon

881.25

Current Price

EMA & SMApin

Bullish Moving Averages

14

Bearish Moving Averages

6

5 Day 789.14

9 Day 799.57

10 Day 801.57

12 Day 817.45

14 Day 824.47

20 Day 850.27

26 Day 865.77

50 Day 950.35

100 Day 1026.70

200 Day 1037.43

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ISHARES INDIA SC MAURITIUS COMPANYblockSell03 Oct, 2022₹604.6525,151NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Oct, 2022₹604.651,78,908NSE
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy03 Oct, 2022₹604.6525,151NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Oct, 2022₹604.651,78,908NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
28 Mar, 2025NIRAYU LIMITEDAcquisition₹905.1312,665NSE
24 Mar, 2025NIRAYU LIMITEDAcquisition₹866.747,600NSE
21 Mar, 2025Chirayu Ramanbhai Amin HUFAcquisition₹834.462,000NSE
20 Mar, 2025Chirayu Ramanbhai Amin HUFAcquisition₹832.521,500NSE
18 Mar, 2025Chirayu Ramanbhai Amin HUFAcquisition₹826.255,832NSE
28 Feb, 2025Chirayu Ramanbhai Amin HUFAcquisition₹778.2550,000NSE
26 Feb, 2025Chirayu Ramanbhai Amin HUFAcquisition₹797.917,426NSE
24 Feb, 2025Chirayu Ramanbhai Amin HUFAcquisition₹806.144,247NSE
21 Feb, 2025Chirayu Ramanbhai Amin HUFAcquisition₹811.92959NSE
17 Feb, 2025Chirayu Ramanbhai Amin HUFAcquisition₹812.9010,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
09 May, 2024Rs.11.0000 per share(550%)Final Dividend15 Jul, 202415 Jul, 2024
05 May, 2023Rs.8.0000 per share(400%)Final Dividend28 Jul, 202328 Jul, 2023
02 May, 2022Rs.10.0000 per share(500%)Dividend (Changed Final Dividend as Interim Divided)17 Aug, 202218 Aug, 2022

Announcements

DateSourceDetail
04 Apr, 2025BSE IndiaPlease find enclosed herewith the Certificate under Regulation 74(5) of SEBI (DP) Regulations
03 Apr, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication.
01 Apr, 2025BSE IndiaAlembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for injection, 40 mg/vial (Single Dose Vial)
01 Apr, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled ""Alembic Pharmaceuticals receives USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)"".
26 Mar, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window
26 Mar, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
21 Mar, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange regarding ''Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited API-III Facility at Karakhadi''.
21 Mar, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange regarding ''Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited API-III Facility at Karakhadi''.
17 Mar, 2025NSE IndiaAlembic Pharmaceuticals Limited has informed the Exchange regarding ''Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015''.
17 Mar, 2025BSE IndiaPlease find attached herewith the Intimation under Regulation 30

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & OthersTo consider other business matters.24 Jan, 202503 Feb, 2025
Quarterly Results--21 Oct, 202407 Nov, 2024
Quarterly Results--26 Jul, 202408 Aug, 2024
Audited Results & Final Dividend--19 Apr, 202409 May, 2024
Quarterly Results--19 Jan, 202405 Feb, 2024
Quarterly Results--17 Oct, 202307 Nov, 2023
Quarterly Results--24 Jul, 202304 Aug, 2023
Audited Results & Final Dividend--25 Apr, 202305 May, 2023
Quarterly Results--18 Jan, 202301 Feb, 2023
Quarterly Results--31 Oct, 202211 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group69.61%69.61%69.61%69.48%69.78%
Foreign Institutions +4.17%4.52%4.99%5.89%6.96%
Domestic Institutions +16.05%14.51%12.76%11.6%10.15%
Government0%0%0%0%0%
Public10.17%11.36%12.64%13.03%13.11%
Others0%0%0%0%0%

About Alembic Pharmaceuticals

Alembic Pharmaceuticals is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5874.06 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2024.

Parent Organisation

Alembic Group

Founded

2010

Managing Director

Mr. Pranav Amin

NSE Symbol

APLLTD

Alembic Pharmaceuticals Management

NameDesignation
Mr. Chirayu AminChairman & CEO
Mr. Pranav AminManaging Director
Mr. Shaunak AminManaging Director
Mr. R K BahetiDirector - Finance & CFO
Dr. Archana HingoraniIndependent Director
Mr. Ashok BaratIndependent Director
Mr. Jai DiwanjiIndependent Director
Mr. Manish KejriwalIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Alembic Pharmaceuticals

What is the share price of Alembic Pharmaceuticals?

The share price of Alembic Pharmaceuticals on 04 Apr, 2025 is ₹ 881.25.

What is 52W high and 52W low share price of Alembic Pharmaceuticals?

The highest and lowest 52W share prices of Alembic Pharmaceuticals are ₹ 1296.150 and ₹ 725.600

What is the market cap of Alembic Pharmaceuticals?

The market capitalization of Alembic Pharmaceuticals as of 04 Apr, 2025 is ₹ 17,322.13 Crores

What is the P/E ratio of Alembic Pharmaceuticals?

The current P/E ratio of Alembic Pharmaceuticals as of 04 Apr, 2025 is 44.73

What is the PB ratio of Alembic Pharmaceuticals?

The PB ratio of Alembic Pharmaceuticals as of 04 Apr, 2025 is 3.59

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited